Inventor

CARAVELLA JUSTIN ANDREW

US28 patents

⚠️ This page may combine multiple inventors who share the name “CARAVELLA JUSTIN ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CARAVELLA JUSTIN ANDREW

FORMA THERAPEUTICS INC

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors

FORMA TM2 INC

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Q32 BIO INC

Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide

Fusion protein constructs comprising anti-C3d antibody and factor H

Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator

VALO EARLY DISCOVERY INC

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

VALO HEALTH INC

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors